Internet-of-Things   |  3 min read

How Cloudleaf Helps Big Pharma Streamline For The Future

When it comes to tracking and monitoring an increasingly complex industry landscape, pharmaceutical supply chains pose intricate challenges to meet health and safety standards. Cloudleaf’s value-proposition represents a paradigm shift in enterprise-grade IoT adoption and usage across internal and 3rd partner facilities. By reducing IoT deployment from months to days and adoption costs to a tenth of typical IT system implementations, Cloudleaf is able to deliver immediate and sustained ROI.

Highlights from the article:

“Manufacturers have long known that when it comes to safety of their drugs and medical devices, errors can add up to more than law suits, damage to the brand or lost profits, but pose significant risks to health and life…systems are primarily designed to support the needs of enterprise business processes, information flows, reporting, and data analytics. They do little in the way to streamline operational workflows across various R&D, clinical trials, manufacturing, approval and marketing phases. Long term, this lack of operational visibility can lead to compromised output quality, increased risk, and lower TCO.”

“If maximizing productivity was all the rage yesterday, today is about sustained value, through operational visibility, real-time access to granular asset data, collaborative relationships between stakeholders across manufacturing supply and demand chains.”

“The industry is also moving towards smaller-scale modularized manufacturing. The new servitization economy is requiring manufacturers to be agile and responsive. This means that asset value-chains must be flexible, transparent and offer track & trace technologies that enable manufacturers to scale growth and better absorb external shocks from shifting market conditions, new regulations or potential recalls.”

Read the full article here.